Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

High-intensity Laser Therapy vs Shock Wave for Chronic Supraspinatus Tendinopathy

Official title: High-intensity Laser Therapy Versus Extracorporeal Shock Wave on Tendon Thickness and Occupation Ratio In Patients With Chronic Supraspinatus Tendinopathy

Run by Cairo University · NCT07667998 · Data updated 2026-11-12

This study will test whether high-intensity laser therapy or extracorporeal shock wave therapy more effectively changes tendon thickness and improves shoulder pain and function in adults with chronic supraspinatus tendinopathy.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment69 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJune 30, 2026
Main results expectedApril 25, 2027
Study endsApril 25, 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07667998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-50 with unilateral chronic supraspinatus tendinopathy on the dominant side.

Probably not a fit

Patients may not experience meaningful improvements in pain, ROM, or function with either therapy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with chronic supraspinatus tendinopathy will be assigned to receive either high-intensity laser therapy or extracorporeal shock wave therapy, in addition to conventional care. The trial will measure changes in supraspinatus tendon thickness, subacromial space, occupation ratio, shoulder pain, range of motion, hand strength, and functional disability. The aim is to determine which noninvasive treatment yields better structural and functional outcomes, with outcomes tracked over a defined treatment and follow-up period. No surgical interventions are involved, and both treatments are noninvasive options commonly used for tendinopathy.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief and improved shoulder function with one of the noninvasive therapies.

How similar studies have gone: Prior studies have shown benefits of both high-intensity laser therapy and shock wave therapy for tendinopathies, but direct comparisons in chronic supraspinatus tendinopathy are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients from 18 to 50 years old of both genders.
* Unilateral Chronic Supraspinatus Tendinitis in dominant side
* BMI 18.5-24.9
* Tenderness is found over the supraspinatus as it passes subacromial and anterolateral The patient will report pain with active shoulder elevation in the scapular plane (eg: welders, plate workers, slaughterhouse workers and overhead playing athletes)
* The patient will report pain with resisted isometric abduction.
* The patient will report positive Jobe's test (empty can test)

Exclusion Criteria:

* Post shoulder surgery, traumatic incidents
* Partial tears at surgery
* Massive retracted tears at surgery
* Frozen shoulder Rotator cuff tear
* Glenohumeral or acromioclavicular arthritis
* Implanted pacemaker
* Pregnancy

Where it's running

  • Cairo University - faculty of physical therapy outpatient clinic
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.